PortalPublikationenIn vitro susceptibilities of enterococcal blood culture isol...

In vitro susceptibilities of enterococcal blood culture isolates from the Hamburg area to ten antibiotics.

Standard

In vitro susceptibilities of enterococcal blood culture isolates from the Hamburg area to ten antibiotics. / Elsner, H A; Sobottka, Ingo; Feucht, H H; Claussen, M; Kaulfers, P M; Laufs, R; Mack, D.

in: CHEMOTHERAPY, Jahrgang 46, Nr. 2, 2, 2000, S. 104-110.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Elsner, HA, Sobottka, I, Feucht, HH, Claussen, M, Kaulfers, PM, Laufs, R & Mack, D 2000, 'In vitro susceptibilities of enterococcal blood culture isolates from the Hamburg area to ten antibiotics.', CHEMOTHERAPY, Jg. 46, Nr. 2, 2, S. 104-110. <http://www.ncbi.nlm.nih.gov/pubmed/10671760?dopt=Citation>

APA

Elsner, H. A., Sobottka, I., Feucht, H. H., Claussen, M., Kaulfers, P. M., Laufs, R., & Mack, D. (2000). In vitro susceptibilities of enterococcal blood culture isolates from the Hamburg area to ten antibiotics. CHEMOTHERAPY, 46(2), 104-110. [2]. http://www.ncbi.nlm.nih.gov/pubmed/10671760?dopt=Citation

Vancouver

Elsner HA, Sobottka I, Feucht HH, Claussen M, Kaulfers PM, Laufs R et al. In vitro susceptibilities of enterococcal blood culture isolates from the Hamburg area to ten antibiotics. CHEMOTHERAPY. 2000;46(2):104-110. 2.

Bibtex

@article{1b2038d4a6b144848e0aef7a7127b8cc,
title = "In vitro susceptibilities of enterococcal blood culture isolates from the Hamburg area to ten antibiotics.",
abstract = "Treatment of enterococcal infections is often difficult because of intrinsic and acquired resistance to a variety of antimicrobial agents. Between January 1993 and May 1997, enterococci were isolated from blood cultures of 117 patients at the Institute of Medical Microbiology and Immunology, University Hospital Eppendorf, Hamburg, Germany. Eightynine (76%) isolates were phenotypically identified as Enterococcus faecalis, and 24 (21%) as Enterococcus faecium. All E. faecalis isolates, but only 17% of the E. faecium isolates were susceptible to ampicillin. Two E. faecium isolates (8%) but no E. faecalis were vancomycin resistant (vanA genotype). Quinupristin/dalfopristin shows a high degree of susceptiblity of E. faecium (79%) and may be suitable for the therapy of infections caused by glycopeptide-resistant E. faecium strains.",
author = "Elsner, {H A} and Ingo Sobottka and Feucht, {H H} and M Claussen and Kaulfers, {P M} and R Laufs and D Mack",
year = "2000",
language = "Deutsch",
volume = "46",
pages = "104--110",
journal = "CHEMOTHERAPY",
issn = "0009-3157",
publisher = "S. Karger AG",
number = "2",

}

RIS

TY - JOUR

T1 - In vitro susceptibilities of enterococcal blood culture isolates from the Hamburg area to ten antibiotics.

AU - Elsner, H A

AU - Sobottka, Ingo

AU - Feucht, H H

AU - Claussen, M

AU - Kaulfers, P M

AU - Laufs, R

AU - Mack, D

PY - 2000

Y1 - 2000

N2 - Treatment of enterococcal infections is often difficult because of intrinsic and acquired resistance to a variety of antimicrobial agents. Between January 1993 and May 1997, enterococci were isolated from blood cultures of 117 patients at the Institute of Medical Microbiology and Immunology, University Hospital Eppendorf, Hamburg, Germany. Eightynine (76%) isolates were phenotypically identified as Enterococcus faecalis, and 24 (21%) as Enterococcus faecium. All E. faecalis isolates, but only 17% of the E. faecium isolates were susceptible to ampicillin. Two E. faecium isolates (8%) but no E. faecalis were vancomycin resistant (vanA genotype). Quinupristin/dalfopristin shows a high degree of susceptiblity of E. faecium (79%) and may be suitable for the therapy of infections caused by glycopeptide-resistant E. faecium strains.

AB - Treatment of enterococcal infections is often difficult because of intrinsic and acquired resistance to a variety of antimicrobial agents. Between January 1993 and May 1997, enterococci were isolated from blood cultures of 117 patients at the Institute of Medical Microbiology and Immunology, University Hospital Eppendorf, Hamburg, Germany. Eightynine (76%) isolates were phenotypically identified as Enterococcus faecalis, and 24 (21%) as Enterococcus faecium. All E. faecalis isolates, but only 17% of the E. faecium isolates were susceptible to ampicillin. Two E. faecium isolates (8%) but no E. faecalis were vancomycin resistant (vanA genotype). Quinupristin/dalfopristin shows a high degree of susceptiblity of E. faecium (79%) and may be suitable for the therapy of infections caused by glycopeptide-resistant E. faecium strains.

M3 - SCORING: Zeitschriftenaufsatz

VL - 46

SP - 104

EP - 110

JO - CHEMOTHERAPY

JF - CHEMOTHERAPY

SN - 0009-3157

IS - 2

M1 - 2

ER -